Roivant Sciences (ROIV) Financial Statements

727 Followers

Roivant Sciences Financial Overview

Roivant Sciences's market cap is currently $21.34B. The company's EPS TTM is $-0.45; its P/E ratio is ―; Roivant Sciences is scheduled to report earnings on May 20, 2026, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	$ 8.26M	$ 29.05M	$ 32.71M	$ 31.53M	$ 55.29M
Gross Profit	$ 6.97M	$ 28.14M	$ 31.11M	$ 28.50M	$ 46.32M
Operating Income	$ -1.29B	$ -1.11B	$ -824.93M	$ -809.01M	$ -1.21B
EBITDA	$ -1.28B	$ -1.10B	$ -802.89M	$ -790.16M	$ -910.77M
Net Income	$ -299.77M	$ -171.98M	$ 4.35B	$ -1.01B	$ -845.26M
Balance Sheet
Cash & Short-Term Investments	$ 4.30B	$ 4.89B	$ 6.54B	$ 1.68B	$ 2.06B
Total Assets	$ 5.73B	$ 5.44B	$ 7.22B	$ 2.39B	$ 2.59B
Total Debt	$ 107.44M	$ 100.17M	$ 499.75M	$ 481.40M	$ 283.89M
Net Debt	$ -1.32B	$ -2.62B	$ -6.04B	$ -1.20B	$ -1.78B
Total Liabilities	$ 435.63M	$ 249.74M	$ 773.95M	$ 782.02M	$ 523.70M
Stockholders' Equity	$ 4.53B	$ 4.69B	$ 5.97B	$ 1.16B	$ 1.66B
Cash Flow
Free Cash Flow	$ -758.56M	$ -844.05M	$ -766.65M	$ -856.08M	$ -695.16M
Operating Cash Flow	$ -750.35M	$ -839.45M	$ -765.27M	$ -843.39M	$ -677.73M
Investing Cash Flow	$ -682.33M	$ -1.77B	$ 5.20B	$ -44.27M	$ 303.30M
Financing Cash Flow	$ 134.24M	$ -1.22B	$ 419.36M	$ 499.46M	$ 306.79M

Currency in USD

Roivant Sciences Earnings and Revenue History

Income Statement >

Roivant Sciences Debt to Assets

Balance Sheet >

Roivant Sciences Cash Flow

Cash Flow >

Roivant Sciences Forecast EPS vs Actual EPS

Earnings >